Title : Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study - Ceccanti_2022_Front.Pharmacol_13_982434 |
Author(s) : Ceccanti M , Libonati L , Ruffolo G , Cifelli P , Moret F , Frasca V , Palma E , Inghilleri M , Cambieri C |
Ref : Front Pharmacol , 13 :982434 , 2022 |
Abstract : |
PubMedSearch : Ceccanti_2022_Front.Pharmacol_13_982434 |
PubMedID: 36052140 |
Title : Italian recommendations for the diagnosis and treatment of myasthenia gravis - Evoli_2019_Neurol.Sci_40_1111 |
Author(s) : Evoli A , Antonini G , Antozzi C , DiMuzio A , Habetswallner F , Iani C , Inghilleri M , Liguori R , Mantegazza R , Massa R , Pegoraro E , Ricciardi R , Rodolico C |
Ref : Neurol Sci , 40 :1111 , 2019 |
Abstract : |
PubMedSearch : Evoli_2019_Neurol.Sci_40_1111 |
PubMedID: 30778878 |
Title : Chronic treatment with rivastigmine in patients with Alzheimer's disease: a study on primary motor cortex excitability tested by 5 Hz-repetitive transcranial magnetic stimulation - Trebbastoni_2012_Clin.Neurophysiol_123_902 |
Author(s) : Trebbastoni A , Gilio F , D'Antonio F , Cambieri C , Ceccanti M , de Lena C , Inghilleri M |
Ref : Clin Neurophysiol , 123 :902 , 2012 |
Abstract : |
PubMedSearch : Trebbastoni_2012_Clin.Neurophysiol_123_902 |
PubMedID: 21996001 |